Charcot‐Marie‐Tooth disease in children

Abstract Charcot‐Marie‐Tooth (CMT) disease represents a diverse group of inherited neuropathies with a broad spectrum of symptoms. It is the most prevalent inherited neuropathy, with an estimated prevalence ranging from 9.7 to 82 cases per 100,000 individuals. Despite this, CMT comprises only 118 of...

Full description

Saved in:
Bibliographic Details
Main Authors: Ezgi Saylam, Praveen Kumar Ramani, Ruthwik Duvuru, Brett Haley, Aravindhan Veerapandiyan
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:Annals of the Child Neurology Society
Subjects:
Online Access:https://doi.org/10.1002/cns3.20093
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846114338833694720
author Ezgi Saylam
Praveen Kumar Ramani
Ruthwik Duvuru
Brett Haley
Aravindhan Veerapandiyan
author_facet Ezgi Saylam
Praveen Kumar Ramani
Ruthwik Duvuru
Brett Haley
Aravindhan Veerapandiyan
author_sort Ezgi Saylam
collection DOAJ
description Abstract Charcot‐Marie‐Tooth (CMT) disease represents a diverse group of inherited neuropathies with a broad spectrum of symptoms. It is the most prevalent inherited neuropathy, with an estimated prevalence ranging from 9.7 to 82 cases per 100,000 individuals. Despite this, CMT comprises only 118 of 853 inherited neuropathy entries in the Online Mendelian Inheritance in Man (OMIM) database. This comprehensive review offers a thorough examination of CMT's clinical features, subtypes, genetic underpinnings, and pathomechanisms in pediatric cases. CMT typically manifests as progressively worsening muscle weakness and atrophy, primarily affecting the distal extremities. Patients may also experience foot and ankle deformities, hand atrophy, and other systemic issues. To accurately diagnose CMT, a detailed family history, comprehensive clinical evaluation, nerve conduction studies, and relevant genetic testing are essential. Importantly, establishing a differential diagnosis is crucial during evaluation to rule out other conditions with similar presentations. This review aims to provide clinicians with a valuable resource for diagnosing and managing CMT, emphasizing the need for a streamlined and standardized approach considering advancements in genetic testing and the identification of various subtypes.
format Article
id doaj-art-025e7dd5b3b546c2acfb26bbcc3bec1c
institution Kabale University
issn 2831-3267
language English
publishDate 2024-12-01
publisher Wiley
record_format Article
series Annals of the Child Neurology Society
spelling doaj-art-025e7dd5b3b546c2acfb26bbcc3bec1c2024-12-20T13:23:37ZengWileyAnnals of the Child Neurology Society2831-32672024-12-012425626810.1002/cns3.20093Charcot‐Marie‐Tooth disease in childrenEzgi Saylam0Praveen Kumar Ramani1Ruthwik Duvuru2Brett Haley3Aravindhan Veerapandiyan4Division of Neurology Nationwide Children's Hospital Columbus Ohio USADepartment of Pediatrics, Division of Neurology University of Arkansas for Medical Sciences, Arkansas Children's Hospital Little Rock Arkansas USADepartment of Pediatrics, Division of Neurology University of Arkansas for Medical Sciences, Arkansas Children's Hospital Little Rock Arkansas USADepartment of Pediatrics, Division of Neurology University of Arkansas for Medical Sciences, Arkansas Children's Hospital Little Rock Arkansas USADepartment of Pediatrics, Division of Neurology University of Arkansas for Medical Sciences, Arkansas Children's Hospital Little Rock Arkansas USAAbstract Charcot‐Marie‐Tooth (CMT) disease represents a diverse group of inherited neuropathies with a broad spectrum of symptoms. It is the most prevalent inherited neuropathy, with an estimated prevalence ranging from 9.7 to 82 cases per 100,000 individuals. Despite this, CMT comprises only 118 of 853 inherited neuropathy entries in the Online Mendelian Inheritance in Man (OMIM) database. This comprehensive review offers a thorough examination of CMT's clinical features, subtypes, genetic underpinnings, and pathomechanisms in pediatric cases. CMT typically manifests as progressively worsening muscle weakness and atrophy, primarily affecting the distal extremities. Patients may also experience foot and ankle deformities, hand atrophy, and other systemic issues. To accurately diagnose CMT, a detailed family history, comprehensive clinical evaluation, nerve conduction studies, and relevant genetic testing are essential. Importantly, establishing a differential diagnosis is crucial during evaluation to rule out other conditions with similar presentations. This review aims to provide clinicians with a valuable resource for diagnosing and managing CMT, emphasizing the need for a streamlined and standardized approach considering advancements in genetic testing and the identification of various subtypes.https://doi.org/10.1002/cns3.20093childrenCMThereditary neuropathyneuropathy
spellingShingle Ezgi Saylam
Praveen Kumar Ramani
Ruthwik Duvuru
Brett Haley
Aravindhan Veerapandiyan
Charcot‐Marie‐Tooth disease in children
Annals of the Child Neurology Society
children
CMT
hereditary neuropathy
neuropathy
title Charcot‐Marie‐Tooth disease in children
title_full Charcot‐Marie‐Tooth disease in children
title_fullStr Charcot‐Marie‐Tooth disease in children
title_full_unstemmed Charcot‐Marie‐Tooth disease in children
title_short Charcot‐Marie‐Tooth disease in children
title_sort charcot marie tooth disease in children
topic children
CMT
hereditary neuropathy
neuropathy
url https://doi.org/10.1002/cns3.20093
work_keys_str_mv AT ezgisaylam charcotmarietoothdiseaseinchildren
AT praveenkumarramani charcotmarietoothdiseaseinchildren
AT ruthwikduvuru charcotmarietoothdiseaseinchildren
AT bretthaley charcotmarietoothdiseaseinchildren
AT aravindhanveerapandiyan charcotmarietoothdiseaseinchildren